AAAAAA

   
Results: 1-19 |
Results: 19
DIGOXIN PREVENTS MPTP-INDUCED DOPAMINE DEPLETION IN MOUSE STRIATUM
Authors: JOHNSON SW GANCHER ST WOODWARD WR
Citation: Sw. Johnson et al., DIGOXIN PREVENTS MPTP-INDUCED DOPAMINE DEPLETION IN MOUSE STRIATUM, Neurotoxicology and teratology, 19(5), 1997, pp. 413-415
A 10-YEAR FOLLOW-UP - GENOTYPIC ANALYSIS DISPROVES PHENOTYPIC CLASSIFICATION
Authors: NUTT JG GANCHER ST
Citation: Jg. Nutt et St. Gancher, A 10-YEAR FOLLOW-UP - GENOTYPIC ANALYSIS DISPROVES PHENOTYPIC CLASSIFICATION, Movement disorders, 12(3), 1997, pp. 472-472
EFFECTS OF PALLIDOTOMY ON DYSKINESIAS AND MOTOR SIGNS IN PARKINSONS-DISEASE
Authors: GANCHER ST CARTER JH HAMMERSTAD JP CALHOUN D
Citation: St. Gancher et al., EFFECTS OF PALLIDOTOMY ON DYSKINESIAS AND MOTOR SIGNS IN PARKINSONS-DISEASE, Annals of neurology, 42(3), 1997, pp. 213-213
STRIATONIGRAL PEPTIDES, TOLERANCE, AND SENSITIZATION IN A RODENT MODEL OF PARKINSONS-DISEASE
Authors: GANCHER ST YOUNGMAN S MAYER A
Citation: St. Gancher et al., STRIATONIGRAL PEPTIDES, TOLERANCE, AND SENSITIZATION IN A RODENT MODEL OF PARKINSONS-DISEASE, Annals of neurology, 42(3), 1997, pp. 219-219
APOMORPHINE TOLERANCE IN PARKINSONS-DISEASE - LACK OF A DOSE-EFFECT
Authors: GANCHER ST WOODWARD WR NUTT JG
Citation: St. Gancher et al., APOMORPHINE TOLERANCE IN PARKINSONS-DISEASE - LACK OF A DOSE-EFFECT, Clinical neuropharmacology, 19(1), 1996, pp. 59-64
IDENTIFICATION OF 2 NEW KCNA1 MUTATIONS IN EPISODIC ATAXIA MYOKYMIA FAMILIES
Authors: BROWNE DL BRUNT ERP GRIGGS RC NUTT JG GANCHER ST SMITH EA LITT M
Citation: Dl. Browne et al., IDENTIFICATION OF 2 NEW KCNA1 MUTATIONS IN EPISODIC ATAXIA MYOKYMIA FAMILIES, Human molecular genetics, 4(9), 1995, pp. 1671-1672
APOMORPHINE INFUSIONAL THERAPY IN PARKINSONS-DISEASE - CLINICAL UTILITY AND LACK OF TOLERANCE
Authors: GANCHER ST NUTT JG WOODWARD WR
Citation: St. Gancher et al., APOMORPHINE INFUSIONAL THERAPY IN PARKINSONS-DISEASE - CLINICAL UTILITY AND LACK OF TOLERANCE, Movement disorders, 10(1), 1995, pp. 37-43
NIGRAL IMPLANTATION DIFFERENTIALLY AFFECTS INITIAL AND LONG-TERM DRUGRESPONSE IN RODENTS WITH HEMIPARKINSONISM
Authors: GANCHER ST MAYER A YOUNGMAN S
Citation: St. Gancher et al., NIGRAL IMPLANTATION DIFFERENTIALLY AFFECTS INITIAL AND LONG-TERM DRUGRESPONSE IN RODENTS WITH HEMIPARKINSONISM, Annals of neurology, 38(2), 1995, pp. 330-330
A LOCUS FOR THE NYSTAGMUS-ASSOCIATED FORM OF EPISODIC ATAXIA MAPS TO AN II-CM REGION ON CHROMOSOME 19P
Authors: KRAMER PL YUE Q GANCHER ST NUTT JG BALOH R SMITH E BROWNE D BUSSEY K LOVRIEN E NELSON S LITT M
Citation: Pl. Kramer et al., A LOCUS FOR THE NYSTAGMUS-ASSOCIATED FORM OF EPISODIC ATAXIA MAPS TO AN II-CM REGION ON CHROMOSOME 19P, American journal of human genetics, 57(1), 1995, pp. 182-185
EPISODIC ATAXIA MYOKYMIA SYNDROME IS ASSOCIATED WITH POINT MUTATIONS IN THE HUMAN POTASSIUM CHANNEL GENE, KCNA1
Authors: BROWNE DL GANCHER ST NUTT TG BRUNT ERP SMITH EA KRAMER P LITT M
Citation: Dl. Browne et al., EPISODIC ATAXIA MYOKYMIA SYNDROME IS ASSOCIATED WITH POINT MUTATIONS IN THE HUMAN POTASSIUM CHANNEL GENE, KCNA1, Nature genetics, 8(2), 1994, pp. 136-140
CONTROLLED-RELEASE LEVODOPA CARBIDOPA-25/100 (SINEMET CR-25/100) - PHARMACOKINETICS AND CLINICAL EFFICACY IN UNTREATED PARKINSONIAN-PATIENTS/
Authors: HAMMERSTAD JP WOODWARD WR NUTT JG GANCHER ST BLOCK GA CYHAN G
Citation: Jp. Hammerstad et al., CONTROLLED-RELEASE LEVODOPA CARBIDOPA-25/100 (SINEMET CR-25/100) - PHARMACOKINETICS AND CLINICAL EFFICACY IN UNTREATED PARKINSONIAN-PATIENTS/, Clinical neuropharmacology, 17(5), 1994, pp. 429-434
PARKINSONS-DISEASE DYSKINESIAS
Authors: NUTT JG GANCHER ST
Citation: Jg. Nutt et St. Gancher, PARKINSONS-DISEASE DYSKINESIAS, Neurology, 44(6), 1994, pp. 1187-1187
EFFECT OF PERIPHERAL CATECHOL-O-METHYLTRANSFERASE INHIBITION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA IN PARKINSONIAN-PATIENTS
Authors: NUTT JG WOODWARD WR BECKNER RM STONE CK BERGGREN K CARTER JH GANCHER ST HAMMERSTAD JP GORDIN A
Citation: Jg. Nutt et al., EFFECT OF PERIPHERAL CATECHOL-O-METHYLTRANSFERASE INHIBITION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA IN PARKINSONIAN-PATIENTS, Neurology, 44(5), 1994, pp. 913-919
TOLERANCE TO APOMORPHINE IN PARKINSONS-DISEASE IS NOT DOSE-DEPENDENT
Authors: GANCHER ST NUTT JG WOODWARD WR
Citation: St. Gancher et al., TOLERANCE TO APOMORPHINE IN PARKINSONS-DISEASE IS NOT DOSE-DEPENDENT, Neurology, 44(4), 1994, pp. 10000153-10000153
EPISODIC ATAXIA MYOKYMIA SYNDROME IS ASSOCIATED WITH POINT MUTATIONS IN THE HUMAN POTASSIUM CHANNEL GENE KCNA1 (KV1.1)
Authors: LITT M BROWNE DL GANCHER ST NUTT JG BRUNT ERP SMITH EA
Citation: M. Litt et al., EPISODIC ATAXIA MYOKYMIA SYNDROME IS ASSOCIATED WITH POINT MUTATIONS IN THE HUMAN POTASSIUM CHANNEL GENE KCNA1 (KV1.1), The Journal of general physiology, 104(6), 1994, pp. 10000010-10000010
DURATION AND DOSE-DEPENDENT TOLERANCE TO APOMORPHINE - A RAT MODEL OFPARKINSONISM
Authors: GANCHER ST CRABBE JC WOODWARD WR
Citation: St. Gancher et al., DURATION AND DOSE-DEPENDENT TOLERANCE TO APOMORPHINE - A RAT MODEL OFPARKINSONISM, Neurology, 43(4), 1993, pp. 152-152
EFFECTS OF AN INHIBITOR OF CATECHOL-O-METHYL TRANSFERASE (COMT) ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA
Authors: NUTT JG WOODWARD WR STONE CK BECKNER RM CARTER JH GANCHER ST HAMMERSTAD JP GORDIN A
Citation: Jg. Nutt et al., EFFECTS OF AN INHIBITOR OF CATECHOL-O-METHYL TRANSFERASE (COMT) ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVODOPA, Neurology, 43(4), 1993, pp. 332-332
DEFINITIONS AND CLASSIFICATION OF TIC DISORDERS
Authors: FAHN S BRUUN RD CAINE E COHEN DJ COMINGS DE COMO PG CONNEALLY PM GANCHER ST GOETZ C GOLDEN GS JANKOVIC J KURLAN R LEWITT P PAULS D RIDDLE MA SHAPIRO AK SINGER HS
Citation: S. Fahn et al., DEFINITIONS AND CLASSIFICATION OF TIC DISORDERS, Archives of neurology, 50(10), 1993, pp. 1013-1016
A GENE FOR AUTOSOMAL-DOMINANT EPISODIC ATAXIA MYOKYMIA MAPS TO CHROMOSOME-12P/
Authors: LITT M KRAMER P PHROMCHOTIKUL T GANCHER ST NUTT JG
Citation: M. Litt et al., A GENE FOR AUTOSOMAL-DOMINANT EPISODIC ATAXIA MYOKYMIA MAPS TO CHROMOSOME-12P/, American journal of human genetics, 53(3), 1993, pp. 1036-1036
Risultati: 1-19 |